NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.1325
0.00 (0.00%)
Sep 10, 2025, 1:36 PM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $9.90 million as of September 10, 2025. Its market cap has decreased by -59.33% in one year.
Market Cap
9.90M
Enterprise Value
40.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 9.90M, a decrease of -97.07%. That is a compound annual growth rate of -81.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 9.90M | -58.03% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |